To examine the endocrine disruptive effects of 3-methyl-4-nitrophenol (4-nitro-m-cresol; PNMC) in diesel exhaust particles (DEP), the rat Hershberger assay was carried out using castrated immature rats. Castrated 28-d-old immature male rats were implanted with a 5-mm-long silastic tube containing crystalline testosterone and injected with PNMC subcutaneously at doses 1, 10, or 100 mg/kg for 5 consecutive d. The weights of the livers significantly decreased in the 10 and 100 mg/kg PNMC treatment groups as compared with the control group. The weights of the seminal vesicles significantly increased in the 10 mg/kg PNMC treatment group as compared with the control group. The weights of the Cowper's glands were significantly increased in 1 mg/kg PNMC treatment group compared with the control group. The concentrations of plasma testosterone significantly increased in the 10 and 100 mg/kg PNMC treatment groups, indicating that PNMC induced accumulation of bioactive testosterone released from the implanted tube in circulation. Plasma follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels significantly decreased under all the doses in the PNMC treatment groups, indicating that PNMC acts on the hypothalamus-pituitary axis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1271/bbb.90204 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
3-methyl-4-nitrophenol disturbs the maternal-to-zygotic transition of early embryos by damaging mitochondrial function and histone modification.
Ecotoxicol Environ Saf
January 2025
Key Laboratory of Animal Embryo Engineering and Molecular Breeding of Hubei Province, Institute of Animal Sciences and Veterinary Medicine, Hubei Academy of Agricultural Sciences, Wuhan 430070, China; Hubei Hongshan Laboratory, Wuhan 430070, China. Electronic address:
3-methyl-4-nitrophenol (PNMC), a chemical prevalent in various industries for drug, dye, and leather production, also serves as a primary byproduct of organophosphate insecticides. Despite its global recognition as an endocrine disruptor with documented reproductive toxicity, its detrimental impact on preimplantation embryonic development has yet to be thoroughly investigated. In this study, through the in vitro culture of mice embryos, it was initially observed that even low concentrations of PNMC exposure led to a significant reduction in blastocyst formation and a sharp decline in the ratio of inner cell mass within the blastocysts.
View Article and Find Full Text PDFTargeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair.
Cell Death Dis
August 2022
Vascular Biology Center, Augusta University, Augusta, GA, USA.
Current therapies for treatment of proliferative retinopathy focus on retinal neovascularization (RNV) during advanced disease and can trigger adverse side-effects. Here, we have tested a new strategy for limiting neurovascular injury and promoting repair during early-stage disease. We have recently shown that treatment with a stable, pegylated drug form of the ureohydrolase enzyme arginase 1 (A1) provides neuroprotection in acute models of ischemia/reperfusion injury, optic nerve crush, and ischemic stroke.
View Article and Find Full Text PDFThe effect of 3-Methyl-4-Nitrophenol on the early ovarian follicle development in mice by disrupting the clock genes expression.
Chem Biol Interact
August 2022
College of Biological Science and Technology, Beijing Forestry University, Beijing, 100083, China.
3-Methyl-4-Nitrophenol (PNMC) is the main degradation product of organophosphate insecticide fenitrothion and a major component of diesel exhaust particles, which is now becoming a widely spread environmental endocrine disruptor. Previous reports showed PNMC exposure can affect the female reproductive system and ovarian function; however, the mechanism remains unclear. The main purpose of this study is to clarify the mechanism underlying the adverse effects of neonatal PNMC treatment on ovarian functions.
View Article and Find Full Text PDFPreclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury.
Exp Neurol
February 2022
Vascular Biology Center, Augusta University, Augusta, GA, USA; Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Cellular Biology & Anatomy, Augusta University, Augusta, GA, USA; Charlie Norwood VA Medical Center, Augusta, GA, USA. Electronic address:
Arginase 1 (A1) is the enzyme that hydrolyzes the amino acid, L-arginine, to ornithine and urea. We have previously shown that A1 deletion worsens retinal ischemic injury, suggesting a protective role of A1. In this translational study, we aimed to study the utility of systemic pegylated A1 (PEG-A1, recombinant human arginase linked to polyethylene glycol) treatment in mouse models of acute retinal and brain injury.
View Article and Find Full Text PDFPine Needle Extract Applicable to Topical Treatment for the Prevention of Human Papillomavirus Infection.
J Microbiol Biotechnol
January 2021
Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea.
Most cervical cancers are associated with high-risk human papillomavirus (HPV) infection. Currently, cervical cancer treatment entails surgical removal of the lesion, but treatment of infection and preventing tissue damage are issues that still remain to be addressed. Herbal medicine and biological studies have focused on developing antiviral drugs from natural sources.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!